Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Thrombocytosis 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Meningeal Carcinomatosis 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Hepatitis B, Chronic 1Hepatitis B 1Carcinoma, Hepatocellular 1Brain Neoplasms 1

Interventions

pembrolizumab 1peginterferon alfa-2b 1osimertinib 1Radiotherapy 1Pemetrexed 1Interferons 1Drug Therapy 1Cyclophosphamide 1AZD3759 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Meningeal Carcinomatosis × peginterferon alfa-2b × Clear all
NCT07199413 2025-09-30

Allogeneic, Antigen-Presenting, GM-CSF-secreting, SV-BR-1-GM Whole Cell-Therapeutic Vaccine and Immunotherapy: A Phase I Pilot Safety and Feasibility Study for Solid Tumor Patients With CNS Metastases

Medical College of Wisconsin

Phase 1 Not yet recruiting
20 enrolled
CNS

Brain Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡